
percentage of 54.9 %; tracheal stenosis post prolonged intubation or tracheostomy is the most
common reason, especially with the submergence with COVID in 2020 (
7
). RB was a first-line
treatment before moving on to other invasive procedures like tracheal resection and anastomosis
or tracheostomy. A silicone stent was placed in 66% of benign airway stenosis; the stent used is
type Dumon. And only 3 Y-shaped stents were placed during the 8-year period. Their placement
is much more difficult than regular silicone stents. Different techniques have been described to
properly place a Y shape but remain operator-dependent (
8
). As for the Malignant airway stenosis,
pulmonary cancer obstruction (n=21) followed by primary tracheal tumors (n=13) were more
prevalent of malignant etiologies; Rigid bronchoscopy improved the survival rate, especially with
tumor debulking. Stent placement was avoided in most cases because most stents used in this
study were silicone although proven effective in benign stenosis, but has yet to be discussed in
their benefit in tumoral obstruction as palliative treatment (9).
Only 16,43% of patients required a minimum of a second RB and the most common reason was
granulation tissue removal in 41.3% of the cases. 18.5% of patients developed granuloma tissue
after silicone stent placement. In other studies, Chung and al (
10
) found granulation tissue was
noted in 15.2% of patients with Self Expanding Metal Stents (SEMS). Ost and Al (
11
) compared
different kinds of stents and granulation tissue formation rates according to every type of stent
placed; it was found that silicone stents were more likely to develop granulation tissue in a shorter
period. The average time, in our study, between granuloma tissue formation after silicone stent
placement is 13,2 months with an IQR of 6 to 21 months. Similar results have been found in
Verma and al with silicone and SEMS (
1
). A shorter time was noted in Chung and al of 2.6 months
with the use of SEMS (10).
There is a wide range of complications concerning Rigid Bronchoscopy, from simple mucostasis to
hypoxic arrest (
8
). However; during this study, complications have been few and merely related
to the procedure’s failure to fulfill its therapeutic purpose; where a secondary procedure was
needed; such as a second Rigid Bronchoscopy for stent migration; tracheostomy and resection
anastomosis when rigid bronchoscopy wasn’t enough to treat tracheal stenosis.
Conclusion
Rigid bronchoscopy remains the gold standard for the management of many complex airway
pathologies and also for prolonging survival for terminal-stage cancer. Whether used by inter-
ventional pneumologists or thoracic surgeons, its indications remain present despite flexible
bronchoscopy. It is also safe in the hands of a well-trained specialist and has an economic ben-
efit if repetitive FB can be avoided and direct indication for Rigid bronchoscopy is maintained,
especially when there is granulation tissue formation.
Conflict Of Interest
Author declare no conflict of interest and no funding for this study.
References
[1]
Verma A, Tai DY, Goh SK, Goyal R, Kor AC, Ng AW. Review of a 10-year experience of rigid
bronchoscopy at a tertiary centre in Singapore. Precision and Future Medicine. 2020;4(3):99-
106.
[2]
Petrella F, Borri A, Casiraghi M, Cavaliere S, Donghi S, Galetta D, et al. Operative rigid
bronchoscopy: indications, basic techniques and results. Multimed Man Cardiothorac Surg.
2014;2014:mmu006.
[3]
Paradis TJ, Dixon J, Tieu BH. The role of bronchoscopy in the diagnosis of airway disease.
Journal of thoracic disease. 2016;8:3826-37.
140/141